Surgical treatment and lymphedema

Cancer

Volumn 83, Issue 12 SUPPL. II, 1998, Pages 2782-2787

  Pressman, Peter I ^a,b,c  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b LENOX HILL HOSPITAL   (United States)

^c NONE   (United States)

Author keywords

Axilla; Breast carcinoma; Lymphadenectomy; Sentinel node biopsy

Indexed keywords

AXILLARY LYMPH NODE; BREAST CARCINOMA; CANCER SCREENING; CANCER SIZE; CANCER STAGING; CONFERENCE PAPER; HUMAN; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; LYMPHEDEMA; MAMMOGRAPHY; PRIORITY JOURNAL; PROGNOSIS;

EID: 0032535628     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(sici)1097-0142(19981215)83:12b+<2782::aid-cncr26>3.0.co;2-2     Document Type: Conference Paper

References (38)

1. Halsted WS. The result of operations for the cure of cancer of the breast. Ann Surg 1907;46:1-9.
2. Dalh-Iversen E, Tobiassen T. Radical mastectomy with parasternal and supraclavicular dissection for mammary carcinoma. Ann Surg 1963;157:170-5.
3. Urban JA. Radical excision of the chest wall for mammary cancer. Cancer 1951;4:263-85.
4. Veronesi U, Valagussa P. Inefficacy of internal mammary nodes dissection in breast cancer surgery. Cancer 1981;47: 170-5.
5. Fisher B, Montague E. Comparison of radical mastectomy with alternative treatments for primary breast cancer. Cancer 1977;39:2829-39.
6. Fisher B. Laboratory and clinical research in breast cancer - a personal adventure: The David Karnovsky Memorial Lecture. Cancer Res 1980;40:3863-74.
7. Hellman S. Natural history of small breast cancers. J Clin Oncol 1994;12:2229-34.
8. Fisher B, Bauer M, Margolese R, Poisson R, Pilch Y, Redmond C, et al. Five-year results of a randomized clinical trial comparing total mastectomy and segmental mastectomy with or without radiation in the treatment of breast cancer. N Engl J Med 1985;312:665-73.
9. Mustafa I, Bland K. Indications for axillary dissection in T1 breast cancer. Ann Surg 1998;5:4-8.
10. Petrak JA, Blackwood MM. Axillary dissection: current practice and technique. Curr Probl Surg 1995;32:312-4.
11. Patey DH, Dyson WH. Prognosis of carcinoma of the breast in relation to type of operation performed. Br J Cancer 1948;2:7-12.
12. Auchincloss H. Significance of location and number of axillary metastases in carcinoma of the breast. Ann Surg 1963; 158(1):37-46.
13. Hirshaut Y, Pressman P. Breast cancer - the complete guide. New York: Bantam Books, 1996:114.
14. Recht A, Houlihan MJ. Axillary lymph nodes and cancer. Cancer 1995;76:1491-512.
15. Fisher B, Redmond C, Fisher ER, Bauer M, Wolmark N, Wickerham DL, et al. Ten-year results of a randomized clinical trial comparing radical mastectomy and total mastectomy with or without radiation. N Engl J Med 1985;312: 674-81.
16. Cabanes PA, Salmon RJ, Vilcoq JR, Durand JC, Fourquet A, Gautier C, Asselain B. Value of axillary dissection in addition to lumpectomy and radiotherapy in early breast cancer. Lancet 1992;339:1245-8.
17. Harris JR, Osteen RT. Patients with early breast cancer benefit from effective axillary treatment. Breast Cancer Res Treat 1985;5:17-21.
18. Orr R. The impact of prophylactic axillary node dissection on breast cancer survival - a Bayesian meta-analysis [abstract]. Proc Soc Surg Oncol. San Diego, CA. March 26-29, 1998.
19. Early Breast Cancer Trialist's Cooperative Group. Systemic treatment for early breast cancer by hormonal, cytotoxic or immune therapy: 133 randomized trials involving 31,000 recurrences and 24,000 deaths among 75,000 women. Lancet 1992;339:71-85.
20. Lin PP, Allison DC, Wainstock J, Miller KD, Dooley WC, Friedman N, Baker RR. Impact of axillary lymph node dissection on the therapy of breast cancer patient. J Clin Oncol 1993;11:1536-44.
21. isher B, Wolmark N, Bauer M, Redmond C, Gebhardt, M. The accuracy of clinical nodal staging and of limited axillary dissection as a determinant of histological nodal status in carcinoma of the breast. Surg Gynecol Obstet 1981;152:765-72.
22. Danforth D, Findlay P, McDonald H. Complete axillary lymph nodes dissection for Stage I-II carcinoma of the breast. J Clin Oncol 1986;4:655-62.
23. Kissin MW, Thompson EM, Price AB, Slavin G, Kark AE. The inadequacy of axillary sampling in breast cancer. Lancet 1982;1:1210-2.
24. Veronesi U, Rilke F, Luini A, Sacchini V, Galimberti V, Campa T, et al. Distribution of axillary nodes metastases by level of invasion: an analysis of 539 cases. Cancer 1987;59: 682-7.
25. Giuliano AE, Kirgan DM, Guenther JM, Morton DL. Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg 1994;222:394-401.
26. Krag DN, Weaver DL, Alex JC, Fairbank JT. Surgical resection and radiolocalization of the sentinel lymph node in breast cancer using a gamma probe. Surg Oncol 1993;2:335-40.
27. Giuliano A, Jones R, Brennan M, Statman R. S=entinel lymphadenectomy in breast cancer. J Clin Oncol 1997;15: 2345-50.
28. Biassoni L, Granowska M, Carroll MJ, Mather SJ, Howell R, Ellison D, et al. 99m Tc-labelled SM3 in the preoperative evaluation of axillary lymph nodes and primary breast cancer with change detection statistical processing as an aid to tumour detection. Br J Cancer 1998;77:131-8.
29. Avril N, Janicke F, Dose J, Zeigler S, Bense S, Zincke M, et al. Evaluation of axillary lymph node involvement in breast cancer patients using F-18 FDG PET. Eur J Nucl Med 1995; 22:733-40.
30. Crippa F, Agresti R, Seregni E, Greco M, Pascali C, Bogni A, et al. Prospective evaluation of Flourine-19-FDG Pet in presurgical staging of the axilla in breast cancer. J Nucl Med 1998;39:4-8.
31. Silverstein MJ, Rosser RJ, Gierson ED, Waisman JR, Gamagami P, Hoffman RS. Axillary lymph node dissection for intraductal carcinoma: is it indicated? Cancer 1987;59:1819-24.
32. Silver S, Tavassoli FA. Mammary ductal carcinoma in situ with microinvasion. Cancer 1998(in press).
33. McDivitt RW, Boyce W, Gersell D. Tubular carcinoma of the breast: clinical and pathological observations concerning 135 cases. Am J Surg Pathol 1982;6:401-11.
34. 0 patients with long term follow-up. J Clin Oncol 1993;11:2090-100.
35. Barth A, Craig P, Silverstein MJ. Predictors of axillary lymph node metastases in patients with T1 breast carcinoma. Cancer 1997;79:1918-22.
36. Cady B. The new era in breast cancer. Arch Surg 1996;131: 301-8.
37. Leitch AM, Dodd GD, Costanza M. American Cancer Society guidelines for the early detection of breast cancer update 1997. Cancer 1997;47:150-3.
38. Office of Cancer Communications. Cancer death rate declined for the first time ever in the 90s [press release, November 14, 1996]. Bethesda, MD: National Cancer Institute, 1996.